Clinical Trial Update: Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating testosterone to alleviate pain in men with opioid-induced hypogonadism and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism Male
• Opioid-induced Hypogonadism

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Opioid Use, Pain | Phase 2 | Status: RECRUITING